Stockscreener 앱 받기
4.86
1.02%
-0.05
시간 외 거래:
4.87
0.010
+0.21%
Sophia Genetics Sa 주식(SOPH)의 최신 뉴스
ZHENYU XU sells shares under 10b5-1 plan (SOPH) - Stock Titan
Restricted Stock Units Sale Notice (SOPH) — 10b5-1 Transactions Listed - Stock Titan
1,183 RSUs Listed for Sale by SOPH Insider (NASDAQ: SOPH) - Stock Titan
[144] SOPHiA GENETICS SA SEC Filing - Stock Titan
Jurgi Camblong (SOPH) reports multiple 10b5-1 sales across late 2025–2026 - Stock Titan
Trend Report: Can SOPHiA GENETICS SA continue delivering strong returns2026 Risk Factors & Stock Portfolio Risk Management - baoquankhu1.vn
Growth Recap: Why is SOPHiA GENETICS SA stock going downTake Profit & Accurate Entry/Exit Alerts - baoquankhu1.vn
SOPHiA GENETICS SA (NASDAQ:SOPH) Sees Significant Decrease in Short Interest - MarketBeat
[EFFECT] SOPHiA GENETICS SA SEC Filing - Stock Titan
Sophia Genetics Earnings Call: Growth Surges, Losses Linger - TipRanks
Aug PreEarnings: Can SOPHiA GENETICS SA stock double in the next yearJuly 2025 Momentum & High Yield Equity Trading Tips - baoquankhu1.vn
SOPHiA GENETICS (SOPH) Q4 Loss Deepens And Reinforces Bearish Profitability Concerns - Sahm
Will SOPHiA GENETICS SA stock go up in YEARQuarterly Trade Report & Technical Entry and Exit Alerts - baoquankhu1.vn
SOPHiA GENETICS Q4 Earnings Call Highlights - Defense World
Sophia Genetics SA (SOPH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
SOPH SEC FilingsSophia Genetics Sa 10-K, 10-Q, 8-K Forms - Stock Titan
SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q4 2025 Earnings Call Transcript - Insider Monkey
BTIG Maintains Buy on SOPHiA GENETICS S.A. (SOPH) March 03, 2026 - Meyka
SOPHiA GENETICS (NASDAQ: SOPH) registers 75,000 warrant shares for resale - Stock Titan
BTIG reiterates Sophia Genetics stock rating on customer growth - Investing.com
Fulgent Genetics (FLGT) Earnings Transcript - AOL.com
SOPHiA GENETICS S.A. Q4 2025 Earnings Call Summary - Yahoo Finance
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026 - Finviz
SOPHiA GENETICS (SOPH) Q4 2025 Earnings Transcript - The Globe and Mail
SOPHiA GENETICS SA reports results for the quarter ended December 31Earnings Summary - TradingView
SOPHiA GENETICS SA 2025 Q4ResultsEarnings Call Presentation (NASDAQ:SOPH) 2026-03-03 - Seeking Alpha
SOPHiA GENETICS (NASDAQ:SOPH) Posts Quarterly Earnings Results, Misses Estimates By $0.08 EPS - MarketBeat
Sophia Genetics reports fourth quarter and full year 2025 results - marketscreener.com
SOPHiA GENETICS (SOPH) 2025 20-F flags losses, platform and regulatory risks - Stock Titan
[6-K] SOPHiA GENETICS SA Current Report (Foreign Issuer) | SOPH SEC FilingForm 6-K - Stock Titan
Sophia Genetics Q4 Earnings Summary & Key TakeawaysSophia Genetics (NASDAQ:SOPH) - Benzinga
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results - PR Newswire
A Look at Sophia Genetics's Upcoming Earnings ReportSophia Genetics (NASDAQ:SOPH) - Benzinga
SOPHiA GENETICS (SOPH) to Release Earnings on Tuesday - Defense World
SOPH Should I Buy - Intellectia AI
SOPHiA GENETICS SA expected to post a loss of 24 cents a shareEarnings Preview - TradingView
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Expands By 194.3% - MarketBeat
Why The SOPHiA GENETICS (SOPH) Narrative Is Shifting On Richer Valuation And Growth Expectations - Yahoo Finance UK
SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference - Finviz
SOPHiA GENETICS CEO, president in TD Cowen fireside chat March 4 - Stock Titan
SOPHiA GENETICS (SOPH) Projected to Announce Earnings on Tuesday - MarketBeat
Zhenyu Xu files Rule 144 for SOPH (NASDAQ: SOPH) citing multiple 10b5-1 sales - Stock Titan
Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million - AOL.com
Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough - AOL.com
AI medicine firm SOPHiA GENETICS lines up March 3 earnings call - Stock Titan
Swiss–Japanese Partnership Advances Precision Oncology through Liquid Biopsy and Companion Diagnostics - S-GE
Can SOPHiA GENETICS SA continue delivering strong returns2025 Technical Patterns & Daily Growth Stock Investment Tips - mfd.ru
Aug Patterns: Will SOPHiA GENETICS SA stock go up in YEARQuarterly Performance Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat
Moderna Just Crushed Estimates While Everyone Was Looking the Other Way - AOL.com
Can SOPHiA GENETICS SA (90B) stock deliver double digit returnsJobs Report & Free Safe Capital Growth Stock Tips - mfd.ru
Is SOPHiA GENETICS SA a potential multi baggerJuly 2025 Outlook & Free Fast Gain Swing Trade Alerts - mfd.ru
Why The Story Behind SOPHiA GENETICS (SOPH) Is Shifting After The Latest Target Reset - Yahoo Finance
Day Trade: Can SOPHiA GENETICS SA sustain its profitabilityJuly 2025 Action & Long-Term Investment Growth Plans - baoquankhu1.vn
SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems - Finviz
SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems – Company AnnouncementFT.com - Financial Times
SOPHiA GENETICS Appoints Ken Freedman as Chief Revenue Officer - Quantisnow
Aug Wrap: Can SOPHiA GENETICS SA sustain its profitability2025 Dividend Review & Technical Entry and Exit Tips - baoquankhu1.vn
Painful week for individual investors invested in SOPHiA GENETICS SA (NASDAQ:SOPH) after 11% drop, institutions also suffered losses - simplywall.st
5.94%
자본화:
|
볼륨(24시간):